Empress Therapeutics, which exited stealth mode a year ago, has already discovered 15 drug leads across multiple diseases and target classes. Launched in 2020, the Flagship Pioneering startup is now driving towards filing multiple IND applications within the next 24 months. While AI has played a role in compressing those timelines, the company is focusing…